Patient Decision Aid for Opioid Use Disorder

Description

The aim of the study is to test the effectiveness of the Patient Decision Aid for Opioid Use Disorder (PtDA-MAT) by conducting a stepped-wedge cluster-randomized trial in CA H\&SS (stratified by rural vs. non-rural areas) for adults with OUD. Patient outcomes will be tracked by (1) personal assessments (baseline, 3 months, and 6 months): drug use, overdose, healthcare utilization, and (2) clinical and administrative records (over approximately 24 months): drug treatment status and retention, physical and mental health diagnoses, arrest, incarceration, controlled substance use, and mortality. Multilevel models will be applied to test the intervention effects, controlling for possible temporal trends.

Conditions

Opioid Use Disorder

Talk to us

Study Overview

On this page

Study Details

Study overview

The aim of the study is to test the effectiveness of the Patient Decision Aid for Opioid Use Disorder (PtDA-MAT) by conducting a stepped-wedge cluster-randomized trial in CA H\&SS (stratified by rural vs. non-rural areas) for adults with OUD. Patient outcomes will be tracked by (1) personal assessments (baseline, 3 months, and 6 months): drug use, overdose, healthcare utilization, and (2) clinical and administrative records (over approximately 24 months): drug treatment status and retention, physical and mental health diagnoses, arrest, incarceration, controlled substance use, and mortality. Multilevel models will be applied to test the intervention effects, controlling for possible temporal trends.

Patient Decision Aid for Medication-Assisted Treatment for Opioid Use Disorder

Patient Decision Aid for Opioid Use Disorder

Condition
Opioid Use Disorder
Intervention / Treatment

-

Contacts and Locations

Los Angeles

UCLA Integrated Substance Abuse Programs, Los Angeles, California, United States, 90049

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Opioid Use Disorder diagnosis and agreement to follow study procedures (including permission to share medical records and other administrative records)
  • * Significant or unstable medical or psychiatric illness that may interfere with study participation

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, Los Angeles,

Yih-Ing Hser, Ph.D., PRINCIPAL_INVESTIGATOR, University of California, Los Angeles

Larissa Mooney, M.D., PRINCIPAL_INVESTIGATOR, University of California, Los Angeles

Study Record Dates

2024-08